Reuters logo
BRIEF-Charles River Laboratories and Chiesi Farmaceutici announce extension of integrated respiratory drug discovery program
2017年3月13日 / 中午12点19分 / 8 个月前

BRIEF-Charles River Laboratories and Chiesi Farmaceutici announce extension of integrated respiratory drug discovery program

March 13 (Reuters) - Charles River Laboratories International Inc-

* Charles River Laboratories and Chiesi Farmaceutici Spa announce extension of integrated respiratory drug discovery program

* To provide Chiesi portfolio of drug discovery capabilities to help test Chiesi’s candidates for preclinical development Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below